Knight Therapeutics | GUD - Pasivo Circulante

Precio De Mercado
7.50
Cambio Diario
0.05 0.67%
Mensual
1.21%
Anual
22.35%
Q2 Expectativa
7.39




Pasivo Circulante Cambio Fecha
Acasti Pharma USD 1.24M 1.08M 2025-09
Akebia Therapeutics USD 162.94M 29.56M 2025-12
Alaunos Therapeutics USD 813K 108K 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Avita Medical AUD 62.68M 77K 2025-12
Canopy Growth CAD 98.29M 17.19M 2025-12
Cronos Group USD 48.19M 7.12M 2025-12
Dianthus Therapeutics USD 30.73M 6.88M 2025-12
Ionis Pharmaceuticals USD 717M 66M 2026-03
IQVIA Holdings USD 8.34B 170M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Moderna USD 1.99B 306M 2025-12
Omeros USD 85.5M 2.28M 2025-06
Organigram Holdings CAD 94.05M 32.11M 2025-12
Organon & Co USD 2.39B 289M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 7.09B 269.8M 2025-12
Xeris Pharmaceuticals USD 109.57M 6.63M 2025-12